Beta
133151

Biochemical study of E-Cadherin and SATB1 in Urothelial Bladder Carcinoma of Egyptian Patients

Article

Last updated: 01 Jan 2025

Subjects

-

Tags

Biochemistry

Abstract

Bladder cancer was considered the third most common tumor in Egypt according to the National Cancer Institute (NCI) registry. However, Transitional cell carcinoma of the urinary bladder represents about 90% of all bladder cancer cases. Method; The aim of the study was to evaluate the expression levels (mRNA and protein) of E-cadherin and special AT-rich sequence binding protein-1 (SATB1) as biomarkers for transitional cell carcinoma (TCC) using immunohistochemistry and quantitative reverse transcription PCR (RT-qPCR) techniques of the Egyptian urinary bladder patients compared to the noncancerous bladder tissues. The study included 48 TCC tissues (41 males and 7 females) of different grades and stages and 12 noncancerous bladder tissues (7 males and 5 females). Results; A statistically significant association regarding smoking and gender were found between the bladder transitional cell carcinoma (BTCC) group and the control group. However, there was no statistically significant difference in comparing the presence of schistosomiasis in both studied groups. The expression of E-cadherin was significantly down expressed and SATB1 was significantly over expressed in TCC tissues compared to the noncancerous bladder tissues at both mRNA and protein levels. Decreased expression of E-cadherin and over expression of SATB1 were statistically associated with tumor stage, tumor grade, and tumor size. On the other hand, no statistically significant difference was detected between the expressions of the two studied genes and either gender or age. A significant association was found between the protein expressions of E-cadherin and SATB1. Pearson correlation test showed significantly negative correlation between mRNA expressions of E-cadherin and SATB1. Conclusion; E-cadherin and SATB1 expressions may be considered as good biochemical markers for the diagnosis and prognosis of transitional cell carcinoma in urinary bladder of Egyptian patients.

DOI

10.21608/ejchem.2020.53106.3099

Keywords

E-Cadherin, SATB1, Transitional cell carcinoma, Immunohistochemistry, and RT-qPCR

Authors

First Name

Arafa

Last Name

Lotfy

MiddleName

Ahmed

Affiliation

Chemistry Department, Biochemistry Division, Faculty of Science, Cairo University, Egypt

Email

rflotfy@yahoo.com

City

02

Orcid

0000-0003-4919-4646

First Name

Mohamed

Last Name

El-Desouky

MiddleName

Ali

Affiliation

Chemistry Department, Biochemistry Division, Faculty of Science, Cairo University, Egypt

Email

ma.des38@yahoo.com

City

Giza

Orcid

0000-0001-5007-5455

First Name

Abeer

Last Name

Bahnasy

MiddleName

Ahmed

Affiliation

Pathology Department, Tissue Culture and Cytogenetic Unite, National Cancer Institute, Cairo University, Egypt

Email

abeerbahnasy0@gmail.com

City

Cairo

Orcid

-

First Name

Hend

Last Name

Abdel-fattah

MiddleName

Fouad

Affiliation

Pathology Department, Tissue Culture and Cytogenetic Unite, National Cancer Institute, Cairo University, Egypt

Email

yousfhend97@yahoo.com

City

Cairo

Orcid

-

First Name

Mohamed

Last Name

Kobaisi

MiddleName

Hamed

Affiliation

Pathology Department, National Institute of Urology and Nephrology, Gothi, Egypt

Email

kobaisimohamed2000@gmail.com

City

Cairo

Orcid

-

Volume

64

Article Issue

4

Related Issue

22914

Issue Date

2021-04-01

Receive Date

2020-12-10

Publish Date

2021-04-01

Page Start

2,223

Page End

2,234

Print ISSN

0449-2285

Online ISSN

2357-0245

Link

https://ejchem.journals.ekb.eg/article_133151.html

Detail API

https://ejchem.journals.ekb.eg/service?article_code=133151

Order

49

Type

Original Article

Type Code

297

Publication Type

Journal

Publication Title

Egyptian Journal of Chemistry

Publication Link

https://ejchem.journals.ekb.eg/

MainTitle

Biochemical study of E-Cadherin and SATB1 in Urothelial Bladder Carcinoma of Egyptian Patients

Details

Type

Article

Created At

22 Jan 2023